Barclays raised the firm’s price target on Corteva to $55 from $50 and keeps an Equal Weight rating on the shares post the earnings report. Management pushed back Crop Protection normalization to 2025 versus ending first half of 2024, gave 2025 guidance 5% better than expected, and sees overall volumes increasing in both segments with pricing flat to modestly up in 2024, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CTVA: